Evidence map›Paper›PMID 38374116›Full record

ArticleGenome medicine2024

Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features.

Srinivasa Rao, Clare Verrill, Lucia Cerundolo, Nasullah Khalid Alham, Zeynep Kaya, Miriam O'Hanlon, Alicia Hayes, Adam Lambert, Martha James, Iain D C Tullis and 14 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. 3D pathology-guided microdissection.bioRxiv : the preprint server for biology · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Making Multiplexed Imaging Flexible: Combining Essential Markers With Established Antibody Panels.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 3 institutions in 1 country.

Srinivasa Rao *Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. Srinivasa.rao@nds.ox.ac.uk.ORCID 0000-0003-1889-6530
Clare Verrill *Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Lucia CerundoloNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Nasullah Khalid AlhamNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Zeynep KayaNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Miriam O'HanlonNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Alicia HayesNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Adam LambertNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Martha JamesNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Iain D C TullisDepartment of Oncology, University of Oxford, Oxford, UK.
Jane NiedererNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Shelagh LovellNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Altan OmerNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Francisco LopezNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Tom LeslieNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Francesca BuffaDepartment of Oncology, University of Oxford, Oxford, UK.
Richard J BryantNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Alastair D LambNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Boris VojnovicDepartment of Oncology, University of Oxford, Oxford, UK.
David C WedgeManchester Cancer Research Centre, University of Manchester, Manchester, UK.
Ian G MillsNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Dan J WoodcockNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Ian TomlinsonDepartment of Oncology, University of Oxford, Oxford, UK.
Freddie C HamdyNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
University of Oxford · GBNuffield Orthopaedic Centre · GBUniversity of Manchester · GB

Funding

Cancer Research UK 18444Cancer Research UK 25812Cancer Research UK 28701Cancer Research UK C1380/A18444Cancer Research UK C1994/A28701Wellcome Trust
6 · The paper itself

Abstract

backgroundExtension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on tumour evolution in prostate cancer metastasis, the emergence and evolution of cancer clones at this early stage of expansion and spread are poorly understood. We aimed to delineate the routes of evolution and cancer spread within the prostate and to seminal vesicles and lymph nodes, linking these to histological features that are used in diagnostic risk stratification.

methodsWe performed whole-genome sequencing on 42 prostate cancer samples from the prostate, seminal vesicles and lymph nodes of five treatment-naive patients with locally advanced disease. We spatially mapped the clonal composition of cancer across the prostate and the routes of spread of cancer cells within the prostate and to seminal vesicles and lymph nodes in each individual by analysing a total of > 19,000 copy number corrected single nucleotide variants.

resultsIn each patient, we identified sample locations corresponding to the earliest part of the malignancy. In patient 10, we mapped the spread of cancer from the apex of the prostate to the seminal vesicles and identified specific genomic changes associated with the transformation of adenocarcinoma to amphicrine morphology during this spread. Furthermore, we show that the lymph node metastases in this patient arose from specific cancer clones found at the base of the prostate and the seminal vesicles. In patient 15, we observed increased mutational burden, altered mutational signatures and histological changes associated with whole genome duplication. In all patients in whom histological heterogeneity was observed (4/5), we found that the distinct morphologies were located on separate branches of their respective evolutionary trees.

conclusionsOur results link histological transformation with specific genomic alterations and phylogenetic branching. These findings have implications for diagnosis and risk stratification, in addition to providing a rationale for further studies to characterise the genetic changes causally linked to morphological transformation. Our study demonstrates the value of integrating multi-region sequencing with histopathological data to understand tumour evolution and identify mechanisms of prostate cancer spread.

Indexed as

Prostatic NeoplasmsHumansLymphatic MetastasisMalePhylogenyProstateSeminal VesiclesCancer evolutionHistopathologyIntra-tumour heterogeneityProstate cancerProstate cancer metastasisSpatial genomic analysis

Identifiers

PMID38374116
PMCPMC10877771
OpenAlexW4391925335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.